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differentiation of pox and pox-like diseases
in dromedary Camels
Abdelmalik I Khalafalla1,2*, Khalid A Al-Busada3 and Ibrahim M El-Sabagh4,5Abstract
Background: Pox and pox-like diseases of camels are a group of exanthematous skin conditions that have become
increasingly important economically. Three distinct viruses may cause them: camelpox virus (CMLV), camel parapox
virus (CPPV) and camelus dromedary papilloma virus (CdPV). These diseases are often difficult to differentiate based
on clinical presentation in disease outbreaks. Molecular methods such as PCR targeting species-specific genes have
been developed and used to identify these diseases, but not simultaneously in a single tube. Recently, multiplex
PCR has gained reputation as a convenient diagnostic method with cost-and timesaving benefits.
Methods and results: In the present communication, we describe the development, optimization and validation
of a multiplex PCR assay able to detect simultaneously the genome of the three viruses in one single test allowing
for rapid and efficient molecular diagnosis. The assay was developed based on the evaluation and combination
of published and new primer sets and was validated with viral genomic DNA extracted from known virus strains
(n = 14) and DNA extracted from homogenized clinical skin specimens (n = 86). The assay detects correctly the
target pathogens by amplification of targeted genes, even in case of co-infection. The method showed high
sensitivity, and the specificity was confirmed by PCR-product sequencing.
Conclusion: This assay provide rapid, sensitive and specific method for identifying three important viruses in
specimens collected from dromedary camels with varying clinical presentations.
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Pox and pox-like diseases of camels are a group of exan-
thematous skin conditions that have become increasingly
important economically [1]. They include camelpox, which
is caused by the Camelpox virus (CMLV), of the genus
Orthopoxvirus (OPV) and camel contagious ecthyma
(CCE) also named Auzdik disease or orf in camels, which
is caused by a tentative member of the genus Parapoxvirus
(PPV), both viruses belong to the subfamily Chordopoxviri-
nae and the family Poxviridae. The group also includes
warts or camel papillomatosis caused by the camelus
dromedary papilloma virus (CdPV) [2]. These three viruses
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creativecommons.org/publicdomain/zero/1.0/proliferative cutaneous dermatitis that vary in shape, pat-
tern and distribution of the lesion (Fig. 1).
Camel pox is a highly contagious viral skin disease and
occurs in almost every country in which camel hus-
bandry is practiced [3]. The clinical signs of camelpox
vary from acute to mild infection and may include fever,
lymph node enlargement, face edema, lachrymation,
pendulous lips and pox lesions. Papules and vesicles
first appear on the lips and nostrils and later involve
the whole head, neck, buttock, abdomen, legs and groin
[4]. Outbreaks have been reported in Asia (Bahrain,
Iran, Iraq, Oman, Saudi Arabia, United Arab Emirates,
Yemen, Syria, Afghanistan, southern parts of Russia and
India, and Pakistan) and in Africa (Algeria, Egypt,
Ethiopia, Kenya, Mauritania, Morocco, Niger, Somalia
and Sudan) [5, 6]. The disease is endemic in these coun-
tries and a pattern of sporadic outbreaks occurs with a
rise in seasonal incidence usually during the rainy seasonarticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Clinical manifestation of pox- and pox-like diseases of camels
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Saudi Arabia [7], India [3, 8], Ethiopia [9] and Iran [10].
Localized lesions, mainly around the mouth and nares,
characterize camel contagious ecthyma (CCE) and other
sites may become affected. The causative virus (named
therein camel PPV; CPPV) is a tentative member of the
genus PPV that have not been approved as a species
[11]. Nodules appear on the lips of affected animals
followed in most cases by swelling of the face and some-
times the neck. Papules and vesicles appear later and
within a few days develope into thick scabs and fissured
crusts [4]. This disease results in high morbidity, but
variable mortality rates. It has been reported in camels
in the former USSR, Mongolia, Kenya, Somalia, Sudan,
Arabian Peninsula and India [12, 13]. The disease was
reported to cause a mortality rate reaching 9 % in the
Sudan when it occurs in areas abundant in thorny acacia
trees that cause abrasion to lips allowing replication of
the virus [12]. In Iran, Mombeni [13] also reported 70 %
morbidity and 6 % mortality rates aggravated by second-
ary bacterial infection and starvation due to mouth le-
sions. Contagious ecthyma was recently reported from
Bahrain and Saudi Arabia [14], India [13] and Iran [15].
On the other hand, camel papillomatosis leads to a
wart-like lesion often found around the lips and nostrils
and may be misdiagnosed as a pox disease, especially
when generalized lesions occur [16]. The disease appears
as round, cauliflower-like horny masses mainly found on
the skin of the lips and submandibular area and rarely
on hind and forelimbs [17]. A recent publication [2]
showed that the causative virus is unique and genetically
different from the bovine papilloma virus.
The risk caused by these diseases is not only due to
mortality, which can reach 28 % in camelpox [18] and 9 %
in young camel calves in CCE [19], but also due to loss
in milk and meat production because of calf loss, labor,
and quality of skin. Besides, camelpox can cause humandisease and the first conclusive evidence of zoonotic
CMLV infection in humans, associated with outbreaks in
dromedary camels has been recently reported in India [8].
As the lesions of CCE in affected animals are often in-
distinguishable from lesions caused by CMLV or CdPV,
especially when these diseases co-exist in the same local-
ity and when CCE undergoes a generalized course of
disease, these diseases are not easy to differentiate from
each other based only on clinical manifestations.
Camelpox is routinely diagnosed based on clinical
signs, pathological findings and cellular and molecular
assays. Five complementary techniques might be advised
for camelpox diagnosis: transmission electron micros-
copy (TEM), cell culture isolation, standard polymerase
chain reaction (PCR) assays, immunohistochemistry and
demonstration of neutralizing antibodies. The laboratory
diagnosis of these Pox and pox-like diseases of camels,
with exception of camelpox remains an uneasy task due
to difficulties to isolate and propagate the causative vi-
ruses of CCE and papillomatosis. Even for camelpox the
current classical methods for laboratory diagnosis are
unreliable and time-consuming (virus isolation in cell
culture or embryonated chicken eggs) or not available
(TEM) in countries where this disease is endemic.
Molecular methods such as PCR offer a better ap-
proach for the rapid diagnosis of Pox and pox-like dis-
eases of camels and gel-based and real-time quantitative
PCR (qPCR) assays have been developed. A PCR assay
has been reported that can identify OPVs, including
CMLV [20]. PCR assays have been developed for the de-
tection of PPV infections [21, 22] and Khalafalla et al.
[23] were the first to use PCR for diagnosis of CCE. For
camel papillomatosis the pan papilloma virus specific
primers have been used to detect virus genome and also
used for genotyping [2].
The currently available PCR assays to identify CMLV
are based on the detection of sequences encoding for
Fig. 2 Agarose gel electrophoresis showing optimization of
annealing temperature for the three viruses in the multiplex assay. A
volume of 1 ul plasmid DNA containing 106 plasmid copy numbers
of CPPV, CdPV and CMLV was added to the PCR and the assay was
run in a gradient thermal cycler (BIO-RAD 100) using different
annealing temperatures indicated above the figure. PCR pruducts
were 569, 478 and 226 bp for CPPV, CdPV and CMLV, respectively.
Lane M; 100 bp marker. PCR products were resolved by
electrophoresis in 1.5 % agarose in tris-acetate EDTA (TAE) buffer
(40 mM Tris–acetate pH 8.0,1 mM EDTA) and the gel was stained
with ethidium bromide and photographed CPPV; Camel parapox
virus, CdPV; Camelus dromedary Papilloma Virus, CMLV;
Camelpox virus
Fig. 3 Agarose gel electrophoresis of the multiplex PCR amplified
with plasmid DNA containing 106 copy numbers of three viruses
(CPPV, CdPV and CMLV). PCR was performed with the optimum
reagent concentrations and conditions using multiple and single
combination of the three plasmids.. Lane M; 100 bp marker, All;
mixture of the three plasmid DNA. CPPV; Camel parapox virus, CdPV;
Camelus dromedary Papilloma Virus, CMLV; Camelpox virus, NTC;
non-template control (all PCR components except template DNA).
PCR products were resolved by electrophoresis in 1.5 % agarose in
tris-acetate EDTA (TAE) buffer (40 mM Tris–acetate pH 8.0,1 mM
EDTA) and the gel was stained with ethidium bromide
and photographed
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(HA), the ankyrin repeat protein (C18L) or the DNA
polymerase (DNA pol) genes [20, 24, 25]. ATI gene-
based PCR has been performed with a single set of pri-
mer, which enables the differentiation of OPV species by
producing amplicons of different sizes. Recently, a
single-plex C18L and a duplex C18L-DNA pol PCR have
been developed to specifically identify CMLV and to dif-
ferentiate it from other OPVs, capripoxviruses (CaPV)
and PPVs [26]. Recently, Venkatesan [27] reported the
development of a qPCR for detection and quantitation
of CMLV in clinical specimens.
Single target (monoplex) gel-based or real-time PCR
assays established for Pox and pox-like diseases of
camels require separate amplification of each virus gen-
ome. Therefore, there is a need to develop a single diag-
nostic test capable of precisely detecting multiple
infectious agents simultaneously with comparable speci-
ficity and sensitivity instead of detecting each pathogen
individually. In recent years, efforts have been made to
combine monoplex assays into one multiplex format.
Correct diagnosis and differentiation of these diseases
is essential for control programs. For instance, camelpox
can be prevented using the available killed or live vac-
cines and infection by PPV could result in considerable
losses particularly in the susceptible age group of less
than one year [12]. In addition, camelpox can pose
thread to public health due to its zoonotic nature [8].
In the present work, we report the development of a
multiplex PCR method for simultaneous detection and
differentiation of three important viruses of dromedary
camels directly in DNA extracted from clinical speci-
mens. We also evaluated the performance of the assay
using clinical specimens collected from dromedary
camels in Sudan and Saudi Arabia that showed pox-like
lesions and demonstrated that the developed assay is
specific, sensitive and would be attractive and practical
method alternative to conventional protocols.
Results
Optimized parameters of the monoplex and multiplex PCR
The optimization process was performed using plasmid
DNA construct containing the targeted gene fragments
of the three viruses. The performance of the three sets
of primers was first tested in an individual PCR assay
before combining them in a multiplex format. The optimum
annealing temperature of the multiplex PCR was found
to be 57.5 °C (Fig. 2). The developed multiplex PCR
gave visible DNA bands when a constant concentration
of the three plasmid constructs (106 copy number) con-
taining insert of the targeted genes were tested separately
and when all mixed together (Fig. 3). The assay also per-
formed well using Qiagen Hotstart PCR kit (Qiagen,
Germany) and Multiplex PCR Master Mix (New England
Khalafalla et al. Virology Journal  (2015) 12:102 Page 4 of 10Biolabs, UK). The thermal cycling was performed in a
Tpersonal Thermal Cycler (Biometra, Germany).
The specificity of the multiplex PCR
The developed multiplex PCR was confirmed to be spe-
cific in amplifying DNA fragments of the three plasmid
constructs and in detecting all the known CPPV, CMLV
and CdPV DNAs described in Table 1, which were diag-
nosed initially by monoplex PCR. The assay produced
amplicons of expected sizes that were distinguishable in
the agarose gel; 569, 478 and 226 bp PCR products from
DNAs of known CPPV, CdPV and CMLV, respectively
while no positive signal was obtained when using sheep-
pox virus (SPV), Lumpy skin disease virus (LSDV),
Brucella melitensis (BM) or the no template control
(NTC) (Fig. 4), suggesting that the assay was highly spe-
cific for detection of the target viruses. Furthermore, se-
quencing data confirmed the amplification of expected
DNA sequences from the three viruses (data not shown).
The sensitivity of the multiplex PCR
The PCR sensitivity tests were performed using 10-fold
serial dilution of the DNA plasmid constructs that were
first diluted to contain 109 copy numbers. DNA copy
numbers ranging between 10 and 108 were submitted to
monoplex and multiplex PCR. The lower limit of detec-
tion (LOD) was found to be 103 copy numbers of plasmid
DNA for CPPV and CdPV and 102 for CMLV (Fig. 5). On
the other hand, the LOD was found to be 19 pg for DNA
extracted from purified CMLV-14 reference strain (data
not shown). The sensitivity of the monoplex and multiplex
PCR assays was similar for CMLV, but the sensitivity of
both assays in detecting CPPV and CdPV was 10 fold
lower than for CMLV (Fig. 5).Table 1 List of reference virus strains used in this study
SI No. Virus ID Virus ID/test Coll
1 VD45 CMLV1 Nig
2 Ducapox CMLV UAE
3 CML1 CMLV Iran
4 CMLV-14 CMLV UAE
5 CP/Mg/92/1 CMLV Sud
6 CP/Nw/92/2 CMLV Sud
7 CP/Db/92/3 CMLV Sud
8 CP/Tm/93/6 CMLV Sud
9 CMLV/115 CMLV Sud
10 V1 CPPV2 Sud
11 CCE41 CPPV Sud
12 CCE48 CPPV Sud
13 CdPV1 CdPV3 Sud
14 CdPV2 CdPV Sud
1 CMLV: camelpox virus, 2 CPPV: camel parapox virus, 3 CdPV: camelus dromedary pAnalysis of clinical specimens with the multiplex PCR
The multiplex PCR assay successfully amplified the ex-
pected DNA fragments from 86 clinical materials: CPPV
(n = 42), CdPV (n = 27) and CMLV (n = 17) as shown in
Table 2. Interestingly, the developed assay detected co-
infection with CPPV and CdPV in one clinical specimen
collected at Showak area of eastern Sudan in 2013 (Fig. 6).
This result could only be detected by multiplex PCR as
these specimens were previously diagnosed as CPPV posi-
tive by a monoplex PCR. The multiplex was able to detect
CPPV, CdPV and CMLV DNAs in all analyzed clinical
samples positive by monoplex PCR (Table 2).
Discussion
Search of the literature revealed that diagnosis of the
published outbreaks of CCE was confirmed by TEM [16,
28–33], serology [34, 35] or gel-based PCR [13–15, 23].
For CdPV infection, diagnosis was achieved mainly by
TEM [36,], histopathology [17, 36–38], and gel-based
PCR [2]. On the other hand, various diagnostic techniques
were employed for CMLV infection including virus isola-
tion [7, 10, 39–52], TEM [48], immunohistochemistry [43,
49], gel-based PCR [3, 7–10, 23, 26] and real-time PCR
[27]. Virus isolation in cell culture and embryonated eggs
is time-consuming and besides, cannot be applied for
diagnosis of CPPV and CdPV infections because these vi-
ruses are difficult to cultivate. Even if isolation is possible,
this system may not identify multiple pathogens in a single
clinical specimen because identification depends on the
predominant causative agent and influenced by the select-
ive cell type. EM is rapid and specific in distinguishing the
three viruses, but the equipment needed is expensive and
unaffordable to most laboratories in African and Asia
where camels are raised.ection place Year Reference
er 1981 Nguyen et al. (1989)
1989 Kaaden et al. (1990)
1970 Ramyar and Hessami (1972)
1994 Pfeffer et al. (1996)
an 1992 Khalafalla et al. (1998)
an 1992 Khalafalla et al. (1998)
an 1992 Khalafalla et al. (1998)
an 1993 Khalafalla et al. (1998)
an 1992 Abdellatif et al. (2013)
an 1991 Khalafalla et al. (1994)
an 1993 Khalafalla et al. (2005)
an 1993 Khalafalla et al. (2005)
an 2009 Ure et al. (2011)
an 2009 Ure et al. (2011)
apilloma virus
Fig. 5 Agarose gel electrophoresis showing Limit of detection (LOD) of the
dilutions of the three target gene-plasmids of CPPV, CdPV and CMLV. The c
PCR products were resolved by electrophoresis in 1.5 % agarose in tris-acet
the gel was stained with ethidium bromide and photographed
Fig. 4 Specificity of the optimized multiplex assay in the detection
of individual targets of CPPV (strain CCE41), CdPV (genotype CdPV1)
and CMLV (strain CMLV-14) and unrelated DNAs extracted from SPV
(sheeppox virus), LSDV (Lumpy skin disease virus) and BM (Brucella
melitensis). PCR products were resolved by electrophoresis in 1.5 %
agarose in tris-acetate EDTA (TAE) buffer (40 mM Tris–acetate
pH 8.0,1 mM EDTA) and the gel was stained with ethidium bromide
and photographed
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an almost indispensable part of medical and diagnostic
sciences. Due to extreme sensitivity, PCR methods have
evolved to be the diagnostic method of choice [25, 53].
PCR assays to identify CPPV, CdPV and CMLV have been
described, but to our knowledge, there is no report using
this technique in a multiplex system. Virus-specific PCR
assays that employs separate detection of each virus are
costly compared to multiplex assays. Multiplex PCR is an
approach commonly used to amplify more than one DNA
target regions in a single PCR reaction.
In the present study, we tested several approaches to
develop a multiplex PCR strategy that detects simultan-
eously CMLV, CdPV and CPPV. Previously published
primers were tested in a monoplex and multiplex format
and we selected the best performing published primer
sets for CdPV and CPPV. Since most of the published
OPV genus-specific primer sets produce relatively long
PCR products that affect the sensitivity of the PCR [53]
we designed primer sets that specifically detect CMLV
HA gene with 226 bp product size. In our early PCRmonoplex and multiplex PCR assays employed over 10-fold serial
oncentrations of each plasmid DNA were indicated above each lane.
ate EDTA (TAE) buffer (40 mM Tris–acetate pH 8.0,1 mM EDTA) and
Table 2 Testing clinical specimens to evaluate the performance of Monoplex and Multiplex PCR assays






Sudan/Showak/2000 6 CMLV 6 (100) 6 (100) ND*
Sudan/Showak/2013 8 CMLV 6 (75) 6 (75) 4 (50)
SaudiArabia/Hail/2014 3 CMLV 3 (100) 3 (100) 3 (100)
Sudan/Showak/1993 6 CPPV 4 (66.7) 4 (66.7) 3 (50)
Sudan/Showak/2000 8 CPPV 7 (87.5) 7 (87.5) ND
Sudan/Showak/2005 6 CPPV 6 (100) 6 (100) ND
Sudan/Showak/2012 6 CPPV 4 (66.7) 4 (66.7) ND
Sudan/Showak/2013 5 CPPV 3 (60) 3 (60) ND
Sudan/Showak/2013 8 CPPV 6 (75) 6 (75) ND
Saudi Arabia/Hail/2014 3 CPPV 0 0 ND
Sudan/Showak/1994 5 CdPV 5 (100) 5 (100) ND
Sudan/Khartoum/2009 6 CdPV 5 (83.3) 5 (83.3) ND
Sudan/Showak/2012 4 CdPV 3 (75) 3 (75) ND
Sudan/Showak/2013 3 CdPV 3 (100) 3 (100) ND
Saudi Arabia/Al-Ahsa/2013 3 CdPV 0 0 ND
Saudi Arabia/Al-Ahsa/2014 6 CdPV 4 (66.7) 4 (66.7) 4
Total 86 65 (75.6) 65 (66.7)
ND: not done
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due to sub-optimal specific amplification that might
occur because of the use of degenerate primer sets for
CdPV. Degenerate primers are the only option available
to detect Papilloma virus DNA because of the broad
genetic heterogeneity [54]. Therefore, we used a hot-
start (HS) DNA polymerase as this is one of the most
important strategies to prevent such unwanted non-
specific PCR products at low temperatures during PCR
[55]. The developed multiplex PCR method was able to
simultaneously detect CPPV, CdPV and CMLV DNAs.
The assay was validated with viral genomic extracted
from known virus isolates and DNA extracted from ho-
mogenized clinical skin specimens. The assay was ableFig. 6 Agarose gel electrophoresis showing 17 positive field specimens de
template in a total reaction volume of 50 μl. Lane M; 100 bp marker, NTC;
Lanes 1–5; specimens positive for CPPV, Lane 6; Field specimen with CPPV
12–17; specimens positive for CMLV. PCR products were resolved by electr
Tris–acetate pH 8.0,1 mM EDTA) and the gel was stained with ethidium broto correctly detect the target pathogens by amplification
of targeted genes, even in case of co-infection.
In camels, the occurrence of mixed infections of
camelpox and contagious ecthyma was previously re-
ported [6] using electron microscopy. In the present
study, we report the first co-infection of dromedary
camels with CPPV and CdPV. This is of particular inter-
est because mixed infection usually misses correct diag-
nosis owing to virus load in the most prominent lesion.
Therefore, a rapid, cost effective and precise test that
can simultaneously differentiate these viruses at an early
stage is essential to prevent the spread of these diseases.
The developed multiplex PCR when used to test con-
trol positive plasmids and viruses as well as varioustected by the developed multiplex PCR. A volume of 3 μl DNA was as
non-template control (all PCR components except template DNA),
and CdPV co-infection, Lanes 7–11; specimens positive for CdPV, Lanes
ophoresis in 1.5 % agarose in tris-acetate EDTA (TAE) buffer (40 mM
mide and photographed
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comparable to monoplex assays. The sensitivity of both
assays in detecting CPPV and CdPV is 10 fold lower
than for CMLV. This may be attributed to the fact that
HA primers amplify relatively shorter fragments of PCR
and hence resulted in a higher sensitivity [53].
To evaluate the diagnostic sensitivity results of the devel-
oped multiplex PCR were compared with standard tech-
niques in a subset of the clinical specimens. Among 11
clinical specimens collected in 2013 and 2014 from drom-
edary camels in the Sudan and Saudi Arabia (Table 2),
seven (63.6 %) were positive for CMLV by virus isolation in
Vero cells culture, while nine (81.8 %) were positive in the
developed multiplex PCR. Among six specimens collected
in the Sudan in 1993 (Table 2) the transmission electron
microscopy (TEM) technique previously detected PPV par-
ticles suggestive of CCE in three specimens (50 %) [23],
while the developed assay detected four positive specimens
(66.7 %) (Table 2). On the other hand, four specimens out
of six (66.7 %) collected in Saudi Arabia in 2014 (Table 2)
were found positive in both histopathology and the devel-
oped assay. These data show that the developed assay has
a higher diagnostic performance and would be a reliable
substitute for the detection of these viral diseases of came-
lids in clinical specimens.
Conclusion
The development of a multiplex PCR method for the
simultaneous detection of CMLV, CPPV and CdPV has
been described and evaluated. The method is rapid, spe-
cific and sensitive and has a performance comparable to
conventional monoplex PCR assays.
Methods
Viruses, DNAs and clinical specimens
Known viruses and DNAs used as positive controls for
each pathogen in the present study are listed in Table 1.
These include four reference CMLV strains: VD45 previ-
ously supplied by CIRAD-EMVT, France [56], Dubai
camelpox vaccine (Ducapox), and DNAs extracted from
purified CMLV-1 and CMLV-14 (kindly provided by
Dr. Sophie Duraffour, Rega Institute, leuven, Belgium).
Additionally, some previously published CMLVs isolated
from outbreaks of the disease in Sudan [49], CPPV posi-
tive specimens collected from previous outbreaks [19]
and skin specimens from an outbreak of papilloma infec-
tion in the Sudan [2], as well as the vaccine strain Sudan
CMLV/115 [57] were also included.
Sheeppox virus (SPV) strain SGP0240, Lumpy skin dis-
ease virus (LSDV) strain isolated in the Sudan [58] and
Brucella Melitensis (BM) strain REV 1 original seed (kindly
provided by Dr. Iaam El Sanousi, Veterinary Research Insti-
tute, Sudan) were used as negative controls and in the spe-
cificity experiments.To validate the specificity and sensitivity of the devel-
oped assay a total of eighty-six skin scabs and nodules
which were collected from dromedary camels in Sudan
and Saudi Arabia showing symptoms of pox and pox-
like lesions between 1993 and 2014 (Table 2).
Tissue homogenization and DNA extraction
A 20 % suspension was made of the scab material in tris-
EDTA (TE) buffer (pH 7.4), freeze-thawed at −30 °C, mech-
anically homogenized using a mechanical homogenizer
(TissueRuptor, Qiagen, Germany) and centrifuged at
1500 g for 10 min at 4 °C. Total viral DNA was extracted
from 200 μl of each sample supernatant using GF-1
Viral Nucleic Acid Extraction Kit (Vivantis Technologies,
Malaysia) according to manufacturer instructions. DNA
was also similarly extracted from supernatant of Vero cells
infected with CMLV. Bacterial DNA was extracted from
Brucella Melitensis strain REV culture by a bacterial ex-
traction kit (Vivantis Technologies, Malaysia).
Oligonucleotide primers
The multiplex PCR assay included two sets of published
primers previously described in the literature, but had
never been used simultaneously. The primer set PPP-1/
PPP-4 [21] amplifies a 569 bp region of the conserved
major viral glycoprotein (B2L) gene of PPV, which is a
widely used in PPV diagnosis and genotyping. For the
camelus dromedary papilloma virus (CdPV), we used the
degenerate pan-papilloma virus specific primers de-
scribed by Forslund et al. [54] that target the L1 ORF of
PV (Table 3). For the CMLV, primer sets targeting genes
encoding for the A-type inclusion body (ATI), the
hemagglutinin (HA), the ankyrin repeat protein (C18L)
and the DNA polymerase were initially tested in combin-
ation with the above-mentioned primer sets, but results
were not satisfactory. Therefore, new pair of primers tar-
geting the hemagglutinin (HA) of OPV was designed. Se-
quences of CMLV HA gene originating from different
countries were obtained from the Genbank®. Regions of
high homology in different CMLV strains were identified
by sequence alignment using Clustal-O (http://www.ebi.
ac.uk/Tools/msa/clustalo/). Primers were initially selected
by using Primer Explorer V4 (http://primerexplorer.jp/e/)
and then manually edited. Details on primer sets used in
the present study are shown in Table 3.
The monoplex PCR
PCR amplifications of the B2L gene of PPV and L1 ORF
of PV were performed with primers shown in Table 1 in
a total reaction volume of 25 μl as described by
Inoshima et al. [21] and Forslund et al. [54], respectively.
For the amplification of the CMLV HA gene PCR reac-
tion was performed in a final volume of 25 μl that con-
tained 1× PCR buffer (Vivantis Technologies, Malaysia),
Table 3 Details of oligonucleotide primers used in this study for Multiplex PCR and for construction of standard plasmids
SI No. Name Sequence (5′-3′) Target virus length PCR product size Reference
1 PPP-1 GTCGTCCACGATGAGGAGCT CPPV 20 594 bp Inoshima et al. (2000)
2 PPP-4 TACGTGGGAAGCGCCTCGCT 20
3 FAP59 TAACWGTNGGNCAYCCWTATT CdPV 21 478 bp Forslund et al. (1999)
4 FAP64 CCWATATCWVHCATNTCNCCATC 23
5 HA F3 ACAGTAAGTACATCATCTGGA CMLV 21 226 bp This study
6 HA R3 TCGTGATGTTTTCTACAGTTG 21
Khalafalla et al. Virology Journal  (2015) 12:102 Page 8 of 1010 mM dNTPs mix, 0.4 μM of each primer (HA-F and
HA-R), one unit Taq DNA polymerase (Vivantis Tech-
nologies, Malaysia) and one μl DNA template. The PCR
amplification was carried out in a Tpersonal Thermocycler
(BIOMETRA, Germany) under the following conditions:
initial denaturation at 94 °C for three min followed by 35 -
cycles each included denaturation step at 94 °C for 30 s,
annealing step at 56 °C for 30 s and extension step at
72 °C for 30 s. A final extension step at 72 °C for seven
min was included. PCR products were resolved by
electrophoresis in 1.5 % agarose in TAE buffer (40 mM
Tris–acetate pH 8.0,1 mM EDTA) and the gel, stained
with ethidium bromide and photographed using ultra-
violet gel documentation system (BIOMETRA, Germany).
Plasmid template construction
As quantitative calibration standards, three plasmids
containing targeted DNA fragments were prepared. PCR
assays were carried out to amplify selected genes using
monoplex protocols described above from reference
strains CCE 41 (CPPV), CdPV1 (CdPV) and CP/Mg/92/
1 (CMLV) (Table 1). The PCR products were separated
by agarose gel electrophoresis, purified with a PCR puri-
fication kit (Vivantis Technologies, Malaysia) and the
PCR product was cloned into pBASE/TA vector. The
ligation product was transformed into JM109 E.coli strain.
Positive clones were identified and the plasmid purified
using a commercial kit and sent for sequencing in an au-
tomated ABI 3730 DNA sequencer (Applied Biosystems,
USA) using the BigDye® Terminator v3.1 cycle sequencing
kit chemistry.
Optimization of the multiplex PCR
A number of experiments were carried, several chemical
and thermal conditions were evaluated, and the assay
optimized by adjusting primers and MgCl2 concentra-
tions as well as the thermal cycling temperatures and
duration. The best conditions were established based on
amplicon yield and specificity. Monoplex PCR experi-
ments were carried out before combining them in multi-
plex assays. Ordinary and hot-start Taq DNA polymerases
were tested. PCR was tested with conventional PCR
approach in addition to a hot-start amplification thatemployed heating all PCR components excluding the Taq
DNA polymerase at 94 °C and then addition of the en-
zyme. The multiplex PCR was performed in 50 μl volume
containing 1 μL (106 copy number) of plasmid DNA,
0.8 μM of PPV primers (PPV-1 and PPV-4) and papilloma
virus (PV) (FAP 59 and FAP64), 0.4 μM of OPV primers
(HA-F and HA-R), 1× PCR buffer (Vivantis Technologies,
Malaysia) including 160 mM (NH4)2 SO4, 500 mM Tris–
HCl (pH 9.2),17.5 mM MgCl2 and 0.1 % Triton™ ×-100)
and 10 mM dNTPs mix. A manual hot-start procedure
was followed in which the above PCR components were
heated up to 95 °C for two min and one unit of Chrome
Max Taq DNA polymerase (Vivantis Technologies,
Malaysia) was added at the same temperature followed
by incubation at 95 °C for nine min, 30 cycles of
denaturation (94 °C, one min), annealing (57.5 °C, one
min) and extension (72 °C, one min) and a final exten-
sion at 72 °C for 10 min. The cycling program for the
multiplex PCR has eight steps with a total running time
of two h, 34 min and 18 s. PCR products were resolved
by electrophoresis in 1.5 % agarose in tris-acetate EDTA
(TAE) buffer (40 mM Tris–acetate pH 8.0,1 mM EDTA)
and the gel was stained with ethidium bromide and
photographed. For gel detection, eight μl of PCR prod-
uct was stained with ethidium bromide and resolved on
a 1.5 % agarose gel using TAE buffer.
Specificity and sensitivity
To estimate the specificity, the developed multiplex assay
was tested with all the three plasmid constructs (106 copy
number), known CPPV (8 ng), CdPV (20 ng) and CMLV
(10 ng), SPV (20 ng), LSDV (20 ng) and BM (15 ng) DNAs
in 1 μl templates volume. Furthermore, the expected PCR
products obtained from the experiments were sequenced
to evaluate the specificity of the assay.
The sensitivity of multiplex PCR and the corresponding
monoplex PCR was performed using serial 10-fold dilu-
tion of the plasmid constructs. Plasmid constructs were
first reconstituted in molecular grade-H2O, quantified
(NanoDrop-1000, Thermo Fisher Waltham, USA), 10-fold
serially diluted to contain concentrations of 10-108 copy
numbers /μl and then submitted to monoplex and multi-
plex PCR. Furthermore, 10-fold serial dilution was carried
Khalafalla et al. Virology Journal  (2015) 12:102 Page 9 of 10out for DNA extracted from purified cell culture-strain of
CMLV (CML-14) to evaluate the sensitivity of the mono-
plex and multiplex PCR.
Applicability of the multiplex PCR
To validate the developed multiplex PCR assay success-
fully amplified the expected DNA fragments from 86
DNA samples extracted from homogenized clinical skin
specimens as shown in Table 2. A volume of 3 μl DNA
was as template in a total reaction volume of 50 μl. All
collected CCE, camelpox and camel papillomatosis clin-
ical samples were previously tested using PPV-specific
PCR [21], OPV-specific PCR [59] and Pan-Papilloma
PCR [54] and were confirmed as CPPV, CdPV and
CMLV infections, respectively.
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